PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
We assessed the PREDICT v 2.2 for prognosis of breast cancer patients with pathogenic germline BRCA1 and BRCA2 variants, using follow-up data from 5453 BRCA1/2 carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and the Breast Cancer Association Consortium (BCAC). PREDICT f...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
12 May 2023
|
| In: |
npj Breast cancer
Year: 2023, Jahrgang: 9, Pages: 1-15 |
| ISSN: | 2374-4677 |
| DOI: | 10.1038/s41523-023-00546-x |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41523-023-00546-x Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41523-023-00546-x 
|
| Verfasserangaben: | Taru A. Muranen, Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis, Renske Keeman, Goska Leslie, Michael T. Parsons, Qin Wang, Thomas U. Ahearn, Kristiina Aittomäki, Irene L. Andrulis, Banu K. Arun, Sabine Behrens, Katarzyna Bialkowska, Stig E. Bojesen, Nicola J. Camp, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Susan M. Domchek, Alison M. Dunning, Christoph Engel, D. Gareth Evans, Manuela Gago-Dominguez, Montserrat García-Closas, Anne-Marie Gerdes, Gord Glendon, Pascal Guénel, Eric Hahnen, Ute Hamann, Helen Hanson, Maartje J. Hooning, Reiner Hoppe, Louise Izatt, Anna Jakubowska, Paul A. James, Vessela N. Kristensen, Fiona Lalloo, Geoffrey J. Lindeman, Arto Mannermaa, Sara Margolin, Susan L. Neuhausen, William G. Newman, Paolo Peterlongo, Kelly-Anne Phillips, Miquel Angel Pujana, Johanna Rantala, Karina Rønlund, Emmanouil Saloustros, Rita K. Schmutzler, Andreas Schneeweiss, Christian F. Singer, Maija Suvanto, Yen Yen Tan, Manuel R. Teixeira, Mads Thomassen, Marc Tischkowitz, Vishakha Tripathi, Barbara Wappenschmidt, Emily Zhao, Douglas F. Easton, Antonis C. Antoniou, Georgia Chenevix-Trench, Paul D. P. Pharoah, Marjanka K. Schmidt, Carl Blomqvist and Heli Nevanlinna |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1850426767 | ||
| 003 | DE-627 | ||
| 005 | 20231129141547.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230616s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41523-023-00546-x |2 doi | |
| 035 | |a (DE-627)1850426767 | ||
| 035 | |a (DE-599)KXP1850426767 | ||
| 035 | |a (OCoLC)1389529605 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Muranen, Taru A. |e VerfasserIn |0 (DE-588)1133226094 |0 (DE-627)888967098 |0 (DE-576)489195784 |4 aut | |
| 245 | 1 | 0 | |a PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants |c Taru A. Muranen, Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis, Renske Keeman, Goska Leslie, Michael T. Parsons, Qin Wang, Thomas U. Ahearn, Kristiina Aittomäki, Irene L. Andrulis, Banu K. Arun, Sabine Behrens, Katarzyna Bialkowska, Stig E. Bojesen, Nicola J. Camp, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Susan M. Domchek, Alison M. Dunning, Christoph Engel, D. Gareth Evans, Manuela Gago-Dominguez, Montserrat García-Closas, Anne-Marie Gerdes, Gord Glendon, Pascal Guénel, Eric Hahnen, Ute Hamann, Helen Hanson, Maartje J. Hooning, Reiner Hoppe, Louise Izatt, Anna Jakubowska, Paul A. James, Vessela N. Kristensen, Fiona Lalloo, Geoffrey J. Lindeman, Arto Mannermaa, Sara Margolin, Susan L. Neuhausen, William G. Newman, Paolo Peterlongo, Kelly-Anne Phillips, Miquel Angel Pujana, Johanna Rantala, Karina Rønlund, Emmanouil Saloustros, Rita K. Schmutzler, Andreas Schneeweiss, Christian F. Singer, Maija Suvanto, Yen Yen Tan, Manuel R. Teixeira, Mads Thomassen, Marc Tischkowitz, Vishakha Tripathi, Barbara Wappenschmidt, Emily Zhao, Douglas F. Easton, Antonis C. Antoniou, Georgia Chenevix-Trench, Paul D. P. Pharoah, Marjanka K. Schmidt, Carl Blomqvist and Heli Nevanlinna |
| 264 | 1 | |c 12 May 2023 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.06.2023 | ||
| 520 | |a We assessed the PREDICT v 2.2 for prognosis of breast cancer patients with pathogenic germline BRCA1 and BRCA2 variants, using follow-up data from 5453 BRCA1/2 carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and the Breast Cancer Association Consortium (BCAC). PREDICT for estrogen receptor (ER)-negative breast cancer had modest discrimination for BRCA1 carrier patients overall (Gönen & Heller unbiased concordance 0.65 in CIMBA, 0.64 in BCAC), but it distinguished clearly the high-mortality group from lower risk categories. In an analysis of low to high risk categories by PREDICT score percentiles, the observed mortality was consistently lower than the expected mortality, but the confidence intervals always included the calibration slope. Altogether, our results encourage the use of the PREDICT ER-negative model in management of breast cancer patients with germline BRCA1 variants. For the PREDICT ER-positive model, the discrimination was slightly lower in BRCA2 variant carriers (concordance 0.60 in CIMBA, 0.65 in BCAC). Especially, inclusion of the tumor grade distorted the prognostic estimates. The breast cancer mortality of BRCA2 carriers was underestimated at the low end of the PREDICT score distribution, whereas at the high end, the mortality was overestimated. These data suggest that BRCA2 status should also be taken into consideration with tumor characteristics, when estimating the prognosis of ER-positive breast cancer patients. | ||
| 650 | 4 | |a Breast cancer | |
| 650 | 4 | |a Cancer genetics | |
| 650 | 4 | |a Chemotherapy | |
| 650 | 4 | |a Prognostic markers | |
| 700 | 1 | |a Chang-Claude, Jenny |e VerfasserIn |0 (DE-588)1049304993 |0 (DE-627)781626188 |0 (DE-576)168344475 |4 aut | |
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t npj Breast cancer |d London : Nature Publ. Group, 2015 |g 9(2023), Artikel-ID 37, Seite 1-15 |h Online-Ressource |w (DE-627)844762113 |w (DE-600)2843288-5 |w (DE-576)45358621X |x 2374-4677 |7 nnas |a PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants |
| 773 | 1 | 8 | |g volume:9 |g year:2023 |g elocationid:37 |g pages:1-15 |g extent:15 |a PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41523-023-00546-x |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41523-023-00546-x |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230616 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |d 50000 |e 910000PS109972554 |e 910400PS109972554 |e 50000PS109972554 |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 53 | ||
| 998 | |g 1049304993 |a Chang-Claude, Jenny |m 1049304993:Chang-Claude, Jenny |d 50000 |e 50000PC1049304993 |k 0/50000/ |p 19 | ||
| 999 | |a KXP-PPN1850426767 |e 4339749907 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"display":"Muranen, Taru A.","family":"Muranen","role":"aut","given":"Taru A."},{"given":"Jenny","role":"aut","display":"Chang-Claude, Jenny","family":"Chang-Claude"},{"display":"Schneeweiss, Andreas","family":"Schneeweiss","role":"aut","given":"Andreas"}],"name":{"displayForm":["Taru A. Muranen, Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis, Renske Keeman, Goska Leslie, Michael T. Parsons, Qin Wang, Thomas U. Ahearn, Kristiina Aittomäki, Irene L. Andrulis, Banu K. Arun, Sabine Behrens, Katarzyna Bialkowska, Stig E. Bojesen, Nicola J. Camp, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Susan M. Domchek, Alison M. Dunning, Christoph Engel, D. Gareth Evans, Manuela Gago-Dominguez, Montserrat García-Closas, Anne-Marie Gerdes, Gord Glendon, Pascal Guénel, Eric Hahnen, Ute Hamann, Helen Hanson, Maartje J. Hooning, Reiner Hoppe, Louise Izatt, Anna Jakubowska, Paul A. James, Vessela N. Kristensen, Fiona Lalloo, Geoffrey J. Lindeman, Arto Mannermaa, Sara Margolin, Susan L. Neuhausen, William G. Newman, Paolo Peterlongo, Kelly-Anne Phillips, Miquel Angel Pujana, Johanna Rantala, Karina Rønlund, Emmanouil Saloustros, Rita K. Schmutzler, Andreas Schneeweiss, Christian F. Singer, Maija Suvanto, Yen Yen Tan, Manuel R. Teixeira, Mads Thomassen, Marc Tischkowitz, Vishakha Tripathi, Barbara Wappenschmidt, Emily Zhao, Douglas F. Easton, Antonis C. Antoniou, Georgia Chenevix-Trench, Paul D. P. Pharoah, Marjanka K. Schmidt, Carl Blomqvist and Heli Nevanlinna"]},"physDesc":[{"extent":"15 S."}],"recId":"1850426767","relHost":[{"disp":"PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsnpj Breast cancer","type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"London","publisher":"Nature Publ. Group","dateIssuedDisp":"June 2015-"}],"pubHistory":["02 June 2015-"],"title":[{"title_sort":"npj Breast cancer","title":"npj Breast cancer"}],"part":{"text":"9(2023), Artikel-ID 37, Seite 1-15","extent":"15","volume":"9","year":"2023","pages":"1-15"},"id":{"eki":["844762113"],"issn":["2374-4677"],"zdb":["2843288-5"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"844762113"}],"id":{"eki":["1850426767"],"doi":["10.1038/s41523-023-00546-x"]},"origin":[{"dateIssuedDisp":"12 May 2023","dateIssuedKey":"2023"}],"note":["Gesehen am 16.06.2023"],"title":[{"title":"PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants","title_sort":"PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a MURANENTARPREDICTVAL1220 | ||